ÂÜÀòÂÒÂ×

Eva Blem is a seasoned finance professional with extensive experience in the pharmaceutical industry, currently serving as Senior Director FP&A & Global Anti-Infective Business Finance at Xellia Pharmaceuticals since August 2017. Prior to Xellia, Blem held several key positions at Novo Nordisk from January 2001 to July 2017, including Senior Manager of PS Controlling and Planning, Finance Director for the Biopharm business, and various finance management roles. Early career experience includes a team leader position at Grontmij (Carl Bro) from January 1993 to January 2001. Blem holds a cand merc aud degree from Aarhus University, obtained between 1985 and 1991.